MediciNova, Inc.
Treatment of progressive neurodegenerative disease with ibudilast

Last updated:

Abstract:

Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine).

Status:
Grant
Type:

Utility

Filling date:

1 May 2019

Issue date:

10 Aug 2021